BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31526124)

  • 1. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance.
    Peña-Martínez C; Durán-Laforet V; García-Culebras A; Ostos F; Hernández-Jiménez M; Bravo-Ferrer I; Pérez-Ruiz A; Ballenilla F; Díaz-Guzmán J; Pradillo JM; Lizasoain I; Moro MA
    Stroke; 2019 Nov; 50(11):3228-3237. PubMed ID: 31526124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke.
    Ducroux C; Di Meglio L; Loyau S; Delbosc S; Boisseau W; Deschildre C; Ben Maacha M; Blanc R; Redjem H; Ciccio G; Smajda S; Fahed R; Michel JB; Piotin M; Salomon L; Mazighi M; Ho-Tin-Noe B; Desilles JP
    Stroke; 2018 Mar; 49(3):754-757. PubMed ID: 29438080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke.
    Zhang S; Cao Y; Du J; Liu H; Chen X; Li M; Xiang M; Wang C; Wu X; Liu L; Wang C; Wu Y; Li Z; Fang S; Shi J; Wang L
    FASEB J; 2021 Sep; 35(9):e21835. PubMed ID: 34449927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke.
    Wang R; Zhu Y; Liu Z; Chang L; Bai X; Kang L; Cao Y; Yang X; Yu H; Shi MJ; Hu Y; Fan W; Zhao BQ
    Blood; 2021 Jul; 138(1):91-103. PubMed ID: 33881503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
    Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Trap Targeting Protects Against Ischemic Damage After Fibrin-Rich Thrombotic Stroke Despite Non-Reperfusion.
    Peña-Martínez C; Durán-Laforet V; García-Culebras A; Cuartero MI; Moro MÁ; Lizasoain I
    Front Immunol; 2022; 13():790002. PubMed ID: 35250974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil extracellular traps in ischemic stroke thrombi.
    Laridan E; Denorme F; Desender L; François O; Andersson T; Deckmyn H; Vanhoorelbeke K; De Meyer SF
    Ann Neurol; 2017 Aug; 82(2):223-232. PubMed ID: 28696508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke.
    Desilles JP; Solo Nomenjanahary M; Consoli A; Ollivier V; Faille D; Bourrienne MC; Hamdani M; Dupont S; Di Meglio L; Escalard S; Maier B; Blanc R; Piotin M; Lapergue B; Ajzenberg N; Vasse M; Mazighi M; Ho-Tin-Noé B; ; Désilles JP; Mazighi M; Piotin M; Blanc R; Redjem H; Smajda S; Seners P; Escalard S; Delvoye F; Maier B; Hebert S; Ben Maacha M; Hamdani M; Sabben C; Obadia M; Deschildre C; Lapergue B; Consoli A; Rodesch G; Maria F; Coskun O; Lopez D; Bourcier R; Detraz L; Desal H; Roy M; Clavier D; Marnat G; Gariel F; Lucas L; Sibon I; Eugene F; Vannier S; Ferre JC; LeBras A; Raoult H; Paya C; Gauvrit JY; Richard S; Gory B; Barbier C; Vivien D; Touze E; Gauberti M; Blaizot G; Ifergan H; Herbreteau D; Bibi R; Janot K; Charron V; Boulouis G
    J Thromb Haemost; 2022 Apr; 20(4):919-928. PubMed ID: 35032088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin Modulates Shear-Induced NETosis in Sterile Occlusive Thrombi Formed under Haemodynamic Flow.
    Yu X; Diamond SL
    Thromb Haemost; 2019 Apr; 119(4):586-593. PubMed ID: 30722079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
    Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
    Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.
    Santos EM; Dankbaar JW; Treurniet KM; Horsch AD; Roos YB; Kappelle LJ; Niessen WJ; Majoie CB; Velthuis B; Marquering HA;
    Stroke; 2016 Aug; 47(8):2058-65. PubMed ID: 27338928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis.
    Di Meglio L; Desilles JP; Ollivier V; Nomenjanahary MS; Di Meglio S; Deschildre C; Loyau S; Olivot JM; Blanc R; Piotin M; Bouton MC; Michel JB; Jandrot-Perrus M; Ho-Tin-Noé B; Mazighi M
    Neurology; 2019 Oct; 93(18):e1686-e1698. PubMed ID: 31541014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.
    Denorme F; Langhauser F; Desender L; Vandenbulcke A; Rottensteiner H; Plaimauer B; François O; Andersson T; Deckmyn H; Scheiflinger F; Kleinschnitz C; Vanhoorelbeke K; De Meyer SF
    Blood; 2016 May; 127(19):2337-45. PubMed ID: 26929275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Plasminogen Activator for preclinical stroke research: Neither "rat" nor "human" dose mimics clinical recanalization in a carotid occlusion model.
    Tomkins AJ; Hood RJ; Levi CR; Spratt NJ
    Sci Rep; 2015 Nov; 5():16026. PubMed ID: 26522691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of extracellular DNA improves the outcome of intestinal ischemic reperfusion injury in neonatal rats.
    Boettcher M; Eschenburg G; Mietzsch S; Jiménez-Alcázar M; Klinke M; Vincent D; Tiemann B; Bergholz R; Reinshagen K; Fuchs TA
    Sci Rep; 2017 Nov; 7(1):15377. PubMed ID: 29133856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic stroke and the recanalization drug tissue plasminogen activator interfere with antibacterial phagocyte function.
    Vogelgesang A; Lange C; Blümke L; Laage G; Rümpel S; Langner S; Bröker BM; Dressel A; Ruhnau J
    J Neuroinflammation; 2017 Jul; 14(1):140. PubMed ID: 28732504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of leukocytes in acute ischemic stroke-related thrombosis: a notable but neglected topic.
    Bi R; Chen S; Chen S; Peng Q; Jin H; Hu B
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6251-6264. PubMed ID: 34398251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
    van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
    Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid promotes thrombus stability by inducing rapid formation of neutrophil extracellular traps: A new mechanism of thrombosis.
    Li T; Peng R; Wang F; Hua L; Liu S; Han Z; Pei J; Pei S; Zhao Z; Jiang X; Chen X
    J Thromb Haemost; 2020 Aug; 18(8):1952-1964. PubMed ID: 32291893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.